Table 2.
Variable† | N | Regression coefficient
(95% CI) |
---|---|---|
Intercept | 147 | 2.74 (2.38 to 3.10) |
Age | 147 | −0.01 (−0.01 to 0.00) |
VKORC1 1173 (CT=1) | 74 | −0.40 (−0.53 to −0.27) |
VKORC1 1173 (TT=1) | 13 | −0.82 (−1.05 to −0.59) |
CYP2C9 (any*2=1) | 42 | −0.21 (−0.36 to −0.07) |
CYP2C9 (any*3=1) | 18 | −0.32 (−0.52 to −0.12) |
BMI (less than 25=1) | 50 | −0.18 (−0.35 to −0.01) |
BMI (25 to 30=1) | 59 | −0.19 (−0.35 to −0.03) |
Number of medications that potentiate warfarin | 147 | −0.08 (−0.14 to −0.03) |
Most drinks on one occasion | 147 | 0.03 (0.00 to 0.05) |
History of deep vein thrombosis (yes=1) | 16 | 0.21 (0.01 to 0.41) |
Gender (female=1) | 43 | −0.13 (−0.27 to 0.02) |
Dose (mg/day) = exp[2.74 −(0.01 X age) −(0.40 X VKORC1 1173CT) −(0.82 X VKORC1 1173TT) −(0.21 X CYP2C9 any*2) −(0.32 X CYP2C9 any*3) −(0.18 X BMI <25) −(0.19 X BMI 25 to 30) −(0.08 X number of medications that potentiate warfarin) +(0.03 X most alcoholic drinks on one occasion) +(0.21 X history of deep vein thrombosis) −(0.13 X female)]
Age, number of medications that potentiate warfarin, and most drinks on one occasion were entered as linear terms in the model and dummy variables (0=absent, 1=present) for the other variables.